Use of remote monitoring in the management of system-related complications in implantable defibrillator patients

Netherlands Heart Journal

Volumn 20, Issue 2, 2012, Pages 82-85

  Theuns, D A M J ^a   Jordaens, L ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Arrhythmias; Complications; Implantable cardioverter defibrillator; Lead failure; Remote monitoring

Indexed keywords

ARTICLE; DEFIBRILLATOR; DEVICE SAFETY; DEVICE THERAPY; EARLY DIAGNOSIS; FEASIBILITY STUDY; FOLLOW UP; HEART VENTRICLE ARRHYTHMIA; HUMAN; IATROGENIC DISEASE; LEAD FAILURE; LEAD FRACTURE; OUTPATIENT CARE; PATIENT SAFETY; PRACTICE GUIDELINE; PROTECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; TELECARDIOLOGY; TELEMONITORING;

EID: 84856297376     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0228-8     Document Type: Article

References (25)

1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
2. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibril-lator in advanced chronic heart failure. N Engl J Med. 2004;350:2140-50.
3. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-37.
4. Theuns DA, Smith T, Hunink MG, et al. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis. Europace. 2010;12:1564-70.
5. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA Expert Consensus on the Monitoring of Cardiovascular Implantable Electronic Devices (CIEDs): description of techniques, indications, personnel, frequency and ethical considerations: developed in partnership with the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA); and in collaboration with the American College of Cardiology (ACC), the American Heart Association (AHA), the European Society of Cardiology (ESC), the Heart Failure Association of ESC (HFA), and the Heart Failure Society of America (HFSA). Endorsed by the Heart Rhythm Society, the European Heart Rhythm Association (a registered branch of the ESC), the American College of Cardiology, the American Heart Association. Europace. 2008;10:707-25.
6. Theuns DA, Jordaens LJ. Remote monitoring in implantable defi-brillator therapy. Neth Heart J. 2008;16:53-6.
7. Schoenfeld MH, Reynolds DW. Sophisticated remote implantable cardioverter-defibrillator follow-up: a status report. Pacing Clin Electrophysiol. 2005;28:235-40.
8. Kleemann T, Becker T, Doenges K, et al. Annual rate of trans-venous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years. Circulation. 2007;115:2474-80.
9. Swerdlow CD, Gunderson BD, Ousdigian KT, et al. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation. 2008;118:2122-9.
10. Vollmann D, Erdogan A, Himmrich E, et al. Patient alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace. 2006;8:371-6.
11. Kallinen LM, Hauser RG, Lee KW, et al. Failure of impedance monitoring to prevent adverse clinical events caused by fracture of a recalled high-voltage implantable cardioverter-defibrillator lead. Heart Rhythm. 2008;5:775-9.
12. Nielsen JC, Kottkamp H, Zabel M, et al. Automatic home monitoring of implantable cardioverter defibrillators. Europace. 2008;10:729-35.
13. Hauck M, Bauer A, Voss F, et al. "Home monitoring" for early detection of implantable cardioverter-defibrillator failure: a single-center prospective observational study. Clin Res Cardiol. 2009;98:19-24.
14. Theuns DA, Rivero-Ayerza M, Knops P, et al. Analysis of 57,148 transmissions by remote monitoring of implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2009;32 Suppl 1:S63-5.
15. De Ruvo E, Gargaro A, Sciarra L, et al. Early detection of adverse events with daily remote monitoring versus quarterly standard follow-up program in patients with CRT-D. Pacing Clin Electrophysiol. 2010;34:208-16.
16. Al-Khatib SM, Piccini JP, Knight D, et al. Remote monitoring of implantable cardioverter defibrillators versus quarterly device interrogations in clinic: results from a randomized pilot clinical trial. J Cardiovasc Electrophysiol. 2010;21:545-50.
17. Guedon-Moreau L, Chevalier P, Marquie C, et al. Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J. 2010;31:2246-52.
18. Varma N, Michalski J, Epstein AE, et al. Automatic remote monitoring of implantable cardioverter-defibrillator lead and generator performance: the Lumos-T Safely RedUceS RouTine Office Device Follow-Up (TRUST) trial. Circ Arrhythm Electrophysiol. 2010;3:428-36.
19. Folino AF, Chiusso F, Zanotto G, et al. Management of alert messages in the remote monitoring of implantable cardioverter defibrillators and pacemakers: an Italian single-region study. Euro-pace. 2011;13:1281-91.
20. Varma N, Epstein AE, Irimpen A, et al. Efficacy and safety of automatic remote monitoring for implantable cardioverter-defibrillator follow-up: the Lumos-T Safely Reduces Routine Office Device Follow-up (TRUST) trial. Circulation. 2010;122:325-32.
21. Spencker S, Coban N, Koch L, et al. Potential role of home monitoring to reduce inappropriate shocks in implantable cardioverter-defibrillator patients due to lead failure. Europace. 2009;11:483-8.
22. Gould PA, Krahn AD. Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories. Jama. 2006;295:1907-11.
23. Carlson MD, Wilkoff BL, Maisel WH, et al. Recommendations from the Heart Rhythm Society Task Force on Device Performance Policies and Guidelines Endorsed by the American College of Cardiology Foundation (ACCF) and the American Heart Association (AHA) and the International Coalition of Pacing and Electro-physiology Organizations (COPE). Heart Rhythm. 2006;3:1250-73.
24. Maisel WH, Hauser RG, Hammill SC, et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA). Heart Rhythm. 2009;6:869-85.
25. Perrotta L, Pieragnoli P, Ricciardi G, et al. Multicenter experience with implantable defibrillators subject to recall. Pacing Clin Electrophysiol. 2011;34:998-1002.